1107. Recombinant Adeno-Associated Virus-2 as a Candidate Gene Delivery Vector for Vein Grafts

                 8,          @ 

       

  β"   3   "  

                   

-O99&/           ' ,%β'@A -& F 8988        /  3    -=9H/     

   "



3                        ;     3   =&   ?       3              

             "



  

    β'@A                

     

1105. Potent Inhibition of Neointima Formation by a Tissue Metalloprotease Inhibitor (Timp-1) Delivered through AA VV ectors AAV Vectors Genaro A. Ramirez-Correa,1 Serena Zacchigna,1 Nikola Arsic,1 Lorena Zentilin,1 Daniela Santoro,1 Alessandro Salvi,2 Gianfranco Sinagra,2 Mauro Giacca.1 1 Molecular Medicine, ICGEB, Trieste, Italy; 2Cardiology, Ospedale Maggiore, Trieste, Italy. #  E            3                                    -.(#/ (                

3     3         -##!/ '   

       

          ##! - #!/ C    3        ''.             #!" 8      0      ''.    3    DN                  

             3              

               

      

              

            

 ''.      

                    0  -M,;/ E

 ,??     

 8&", :9  

 3  ''. 69  &9"899 μ     ''." #!8    -8"638988   %/ 



         -M89/ '     

      E 

  E     E  

     ''."DN !2('  

, 6

    >       

        " 8        

            %

 -%#/  "8  

  

   

      ' 6 

 "      %#     ''." 8    9:B±965  



   ,±9;        -!M999=/     &B5H        >        



,

     %#  ''." 8    96B±9,:  8&B±9::I !M 99996 -    ;96H       /            8                    1  3       '           ''.         

                ##!       

           3     3                                   

                    ''.              8          

Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

1106. Adeno-Associated V irus-Mediated Gene Virus-Mediated Transfer in Angiogenic Cultures of Rat Aorta Wen-Hui Zhu,1 Joseph S. McGonigle,2 Monica Iurlaro,1 Eric J. Fogel,3 Jeffrey Bonadio,2 Roberto F. Nicosia.1,3 1 Department of Pathology, University of Washington, Seattle, WA, United States; 2Department of Bioengineering, University of Washington, Seattle, WA, United States; 3Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States. @    

                    

              

           ' " 

  "    

             @                                                         

                    

   ''.,              "         -'!/   

       -?!/ '     

   ''."'! - ''.,        '!

3       @(.   / 3 

   "1 '! 3  -               / 

 

  G        1   

G             

       

   ''."?! - ''.,        ?! 3       #.   /  

   ?! 3         

 3                     

 3  L89"     3      

 ''."'!   ''."?!    

    

                     ''.,       

                                      

1107. Recombinant Adeno-Associated V irus-2 as a Virus-2 Candidate Gene Delivery V ector for V ein Grafts Vector Vein Kate L. Dishart,1 Elisabeth C. Beattie,1 Anna F. Dominiczak,1 Andrew C. Newby,2 Andrew H. Baker.1 1 Department of Medicine and Therapeutics, University of Glasgow, Glasgow, United Kingdom; 2Bristol Heart Institute, Bristol, United Kingdom. !                  -'2/       -(./ 

         

          

   

    

        "   !       

                  "



       -8/ !                       "     3       $ 

               "   

3              E             "

     

    "       ''.",               >  ''."



    3   

  

                       C       

           0   

 ''.,"DN       *5       

    #.    0              (.       -C4(#/        -C(.>/     

                      C D                      "       %       1

         ''.  ,&9     -/%                  3          0   

       

              #8=,   DDD  

      3  89"    ;9"      C4(#   89"    C(.> 

   " 

   ?      $*'      >    

     3              

                                         ''.          C(.>   C4(#

S359

     ''."



          

    "  ''.                ''.            C    

     

           

     E

              6 

         3            "        8, 

     0 A    

                86 3 89 89     %   ''."DN        -

/        

, 6

3

 

 β"   4  ' "DN     

        3     β"                   %

    ,   6 

 " (         "                     

  

3                                      ''.  -             "   

                        

           ''.,    -8/   (<D  ' $* ' 2 'C -,999/ !   .%.7,5B"=96

1108. V on Hippel - Lindau Gene T ransfer into Human Von Transfer Vascular Smooth Muscle Cell Limit Its Proliferative Ability by Regulation of Apoptosis Theresa Jacob,1 Anil Hingorani,1 Enrico Ascher.1 1 Division of Vascular Surgery, Maimonides Medical Center, New York, New York, United States.   7.CD         

 

                   0

     

              " 



                   

                       

    

   

       

               

            

        (

.CD         .>?             3                                   

                "



.CD                 #   7 C         -C'(#/            

              .CD $*' -' .CD/             

     -' ?!/   -' */  "

  

 '         &= -' &=/  

  

              

         >3      

     

       '  

  4*>D            $*'    @ 7 ? ' .CD    C'(#  

   "

         

       -O998/ ' .CD   

   3 

              69,8±8BBH   

    ' &=               



 -O9998/ ' ?!   ' *       C'(#     

      3

      3               ' &=           -;&,;±=&,H/' .CD 3 

6&=B ± ,&&H   C'(# 7     

         "



 .CD 3                   ) 3    .CD    C'(#                 .CD     

     

        .CD                            

             

S360

1109. Gene T ransfer of the T umor Suppressor Transfer Tumor Phosphatase Pten Suppresses Proliferation of V ascular Vascular Smooth Muscle Cells Via the Protein Kinase Akt Laura K. Nolden,1 Harnath S. Shelat,1 Sunil Chada,2 Xin Swanson,2 Lou A. Zumstein,2 James T. Willerson,1 Joe M. Miano,3 Pierre Zoldhelyi.1 1 Gene Therapy Research, Texas Heart Institute and University of Texas-Houston Medical School, Houston, Texas; 2Research Department, Introgen Therapeutics, Houston, Texas; 3 Cardiovascular Research, University of Rochester, Rochester, New York, United States. 0   

     3    ! >*      

  -.(#/             .(#  .(#  

         ! >* -' "! >*  ** ,&8/ ! >*  G

            -#)/  =9   =99 @ .(#   

   B   ' "! >* ' "   -' "D/   

   '  :  .(#  

   ' "D -#) 899/       

   ,389 &  %      6389 &± ,389 6   6=389 & ± B389 6  %    .(#  

   ' "! >*  

  8389 & ± 8,389 6   8&389 & ± 8=389 6  %     ' "! >* #) 899   89 -O9998 

  ' "D #) 899/      ' "! >*.(#  

          "

      ?           .(#   ' "! >* ' "D   

            

   ' "! >*      

   $#>#%2('   "           =9H -#) &9/ 

  ' "D -#) &9/    '

  !$?" 22 -89 %D/    

        ' "D  

   -8,389 &  %  ± 6389 6 #) ,&/      ' "! >*  

           ;9H -' "! >* #) ,&7 &B389 6  %  ± 8&389 6I #) 8,&7 ;B389 6  %  ± 8389 6/ #  

      

  ' "! >*  #) 8    

            

      '   C      

'

 ' "D 

     

'  

  

  ' "! >*  

  ' "



 3   ! >*  .(#       .(#       



     

 ' $*'      ! >*  

    .(#  

  ! >*  

   G

    8     

              3   ! >*                                            

 

 "E

      ' ! >*  &389 5   8389 89 %               

      ! >*  

1110. Adeno-Associated V irus-Mediated Gene Virus-Mediated Transfer into Normal Rabbit Arteries. Assessment of the Tie and CMV Promoters and the Antiproteasome Treatment with MG-132 Marcin Gruchala,1 Katri Pajusola,2 Shalini Bhardwaj,1 Himadri Roy,1 Tuomas Rissanen,1 Seppo Yla-Herttuala.1 1 Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences University of Kuopio, Kuopio, Finland; 2Institute of Molecular Biology, University of Zurich, Zurich, Switzerland. 2                       

            "      3  ' "

   -''./                               "      3         1                       3                ->/        >"   

                         

     ''. 



          E

          

 

       - ?!/                         Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy